Literature DB >> 10195857

The effect of ESWL of renal calculi on pancreatic function.

C Deliveliotis1, F Sofras, G Alivizatos, J Cristofis, E Nazlidou, A Katabekiou.   

Abstract

Fifteen patients were treated by ESWL for renal calculi. The sagittal size of the head, neck and tail of the pancreas, and serum amylase, insulin, c-peptide and 24-hour urine amylase levels were estimated pre and post-treatment. Serum glucose, serum amylase and urinary levels remained within normal limits. Serum levels of insulin, c-peptide and the size of the gland increased but this was not statistically significant. There may be some danger to the pancreas during ESWL as there are some morphological changes even though there are no evident peptide changes. Caution should be taken if patients have a history of pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10195857     DOI: 10.1007/bf02564850

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  5 in total

1.  Methodology, results and complications in 2000 extracorporeal shock wave lithotripsy procedures.

Authors:  F Sofras; A Karayannis; A Kostakopoulos; D Delakas; J Kastriotis; C Dimopoulos
Journal:  Br J Urol       Date:  1988-01

2.  Extracorporeal shock wave lithotripsy: the Methodist Hospital of Indiana experience.

Authors:  J E Lingeman; D Newman; J H Mertz; P G Mosbaugh; R E Steele; R J Kahnoski; T A Coury; J R Woods
Journal:  J Urol       Date:  1986-06       Impact factor: 7.450

3.  Extracorporeal shock wave lithotripsy of pancreatic stones.

Authors:  T Sauerbruch; J Holl; M Sackmann; G Paumgartner
Journal:  Gut       Date:  1989-10       Impact factor: 23.059

Review 4.  Shock wave-induced pancreatic trauma.

Authors:  K D Mullen; J H Hoofnagle; E A Jones
Journal:  Am J Gastroenterol       Date:  1991-05       Impact factor: 10.864

5.  Fragmentation of gallstones by extracorporeal shock waves.

Authors:  T Sauerbruch; M Delius; G Paumgartner; J Holl; O Wess; W Weber; W Hepp; W Brendel
Journal:  N Engl J Med       Date:  1986-03-27       Impact factor: 91.245

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.